Retrospective analysis shows myectomies improved smile metrics in patients with facial synkinesis, indicating botulinum toxin-A may enhance recovery.
Introduction: Selective myectomy has gained popularity for treating facial synkinesis. Objectives & Hypotheses: We examined the combined effectiveness of depressor anguli oris (DAO), partial buccinator, and platysma myectomies. Study Design: Retrospective case series. Methods: Pre- and post-operative botulinum toxin-A (BTX-A) treatments of selective myectomy patients were collected. Facial photographs were analyzed using Emotrics+. Facial Asymmetry Index (FAI) and electronic facial paralysis assessment (eFACE) scores were calculated. Results: Twenty patients underwent myectomies. Improvements (mean ± standard error) were seen in several smile metrics, including FAI by 2.80 mm ± 0.68, nasolabial fold angle by 4.78° ± 1.83, and smile angle by 4.43° ± 1.18 (all p<0.05). Postoperative FAI was 2.79 mm. Total BTX-A decreased by 10.85 units ± 4.48 (p=0.03). eFACE revealed improved oral commissure movement and platysmal synkinesis (p<0.05 for both). Conclusions: Combined myectomies of the DAO, partial buccinator, and platysma clinically and statistically improve smile in facial synkinesis.
No takes yet. Share an insight, caveat, or question.
Krippaehne et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: